Jessica Jane Newman, MD | |
1900 Centracare Cir Ste 2575, Saint Cloud, MN 56303-5000 | |
(320) 229-4924 | |
Not Available |
Full Name | Jessica Jane Newman |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 11 Years |
Location | 1900 Centracare Cir Ste 2575, Saint Cloud, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295078913 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Centracare Health-paynesville Llc | 1153555719 | 28 |
Centracare Clinic | 2466363395 | 632 |
News Archive
A new study has shown how a novel compound boosts levels of a natural painkiller at the site of an injury. The ground-breaking study published today in Nature Neuroscience shows how the potential drug URB937 acts in peripheral tissue and may have the potential to relieve pain without the side effects associated with many current painkillers that act centrally on the nervous system.
MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.
In the Canadian healthcare system, patients with longer than recommended waitlist times for coronary artery bypass graft (CABG) surgery are at increased risk of dying in the hospital, reports Medical Care.
Discovery Laboratories, Inc. today announced that the Company has been awarded Phase I of a Fast Track Small Business Innovation Research Grant (SBIR) from the National Institutes of Health (NIH) to support the development of the Company's program for aerosolizing KL4 surfactant for neonatal respiratory distress syndrome (RDS).
› Verified 1 days ago
Entity Name | Centracare Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
A new study has shown how a novel compound boosts levels of a natural painkiller at the site of an injury. The ground-breaking study published today in Nature Neuroscience shows how the potential drug URB937 acts in peripheral tissue and may have the potential to relieve pain without the side effects associated with many current painkillers that act centrally on the nervous system.
MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.
In the Canadian healthcare system, patients with longer than recommended waitlist times for coronary artery bypass graft (CABG) surgery are at increased risk of dying in the hospital, reports Medical Care.
Discovery Laboratories, Inc. today announced that the Company has been awarded Phase I of a Fast Track Small Business Innovation Research Grant (SBIR) from the National Institutes of Health (NIH) to support the development of the Company's program for aerosolizing KL4 surfactant for neonatal respiratory distress syndrome (RDS).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jessica Jane Newman, MD 1900 Centracare Cir Ste 2575, Saint Cloud, MN 56303-5000 Ph: (320) 229-4924 | Jessica Jane Newman, MD 1900 Centracare Cir Ste 2575, Saint Cloud, MN 56303-5000 Ph: (320) 229-4924 |
News Archive
A new study has shown how a novel compound boosts levels of a natural painkiller at the site of an injury. The ground-breaking study published today in Nature Neuroscience shows how the potential drug URB937 acts in peripheral tissue and may have the potential to relieve pain without the side effects associated with many current painkillers that act centrally on the nervous system.
MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.
In the Canadian healthcare system, patients with longer than recommended waitlist times for coronary artery bypass graft (CABG) surgery are at increased risk of dying in the hospital, reports Medical Care.
Discovery Laboratories, Inc. today announced that the Company has been awarded Phase I of a Fast Track Small Business Innovation Research Grant (SBIR) from the National Institutes of Health (NIH) to support the development of the Company's program for aerosolizing KL4 surfactant for neonatal respiratory distress syndrome (RDS).
› Verified 1 days ago
Christina K Anderson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 | |
Dr. Kyle Erick Rudningen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1900 Centracare Cir Ste 2575, Saint Cloud, MN 56303 Phone: 320-229-4924 Fax: 320-229-4971 | |
John D Mischke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 | |
Dr. Daniel Kevin Elieff, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1510 24th Ave N, Saint Cloud, MN 56303 Phone: 320-259-0208 Fax: 320-259-0715 |